NYSE:ALUR - New York Stock Exchange, Inc. - US02008G2012 - Common Stock - Currency: USD
NYSE:ALUR (5/22/2025, 8:04:00 PM)
2.95
+0.12 (+4.24%)
The current stock price of ALUR is 2.95 USD. In the past month the price increased by 26.61%. In the past year, price decreased by -92.76%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
SCI | SERVICE CORP INTERNATIONAL | 21.28 | 11.04B | ||
HRB | H&R BLOCK INC | 13.18 | 7.71B | ||
ADT | ADT INC | 10.45 | 6.82B | ||
FTDR | FRONTDOOR INC | 15.08 | 3.97B | ||
MCW | MISTER CAR WASH INC | 17.68 | 2.30B | ||
OSW | ONESPAWORLD HOLDINGS LTD | 21.23 | 1.92B | ||
CSV | CARRIAGE SERVICES INC | 14.8 | 661.23M | ||
SDA | SUNCAR TECHNOLOGY GROUP IN-A | N/A | 311.74M | ||
EWCZ | EUROPEAN WAX CENTER INC-A | 8 | 291.51M | ||
JUNE | JUNEE LTD | N/A | 139.47M | ||
YSXT | YSX TECH CO LTD | N/A | 136.13M | ||
RGS | REGIS CORP | 0.6 | 54.44M |
Allurion Technologies, Inc. develops treatments for obesity. The company is headquartered in Natick, Massachusetts and currently employs 134 full-time employees. The company went IPO on 2021-03-29. The firm offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
ALLURION TECHNOLOGIES INC
11 Huron Dr Ste 200
Natick MASSACHUSETTS US
Employees: 503
Phone: 15086474000
The current stock price of ALUR is 2.95 USD. The price increased by 4.24% in the last trading session.
The exchange symbol of ALLURION TECHNOLOGIES INC is ALUR and it is listed on the New York Stock Exchange, Inc. exchange.
ALUR stock is listed on the New York Stock Exchange, Inc. exchange.
10 analysts have analysed ALUR and the average price target is 26.14 USD. This implies a price increase of 786.02% is expected in the next year compared to the current price of 2.95. Check the ALLURION TECHNOLOGIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ALLURION TECHNOLOGIES INC (ALUR) has a market capitalization of 22.01M USD. This makes ALUR a Nano Cap stock.
ALLURION TECHNOLOGIES INC (ALUR) currently has 503 employees.
ALLURION TECHNOLOGIES INC (ALUR) has a support level at 2.82 and a resistance level at 3.18. Check the full technical report for a detailed analysis of ALUR support and resistance levels.
The Revenue of ALLURION TECHNOLOGIES INC (ALUR) is expected to decline by -10.39% in the next year. Check the estimates tab for more information on the ALUR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALUR does not pay a dividend.
ALLURION TECHNOLOGIES INC (ALUR) will report earnings on 2025-08-11.
ALLURION TECHNOLOGIES INC (ALUR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-9.46).
The outstanding short interest for ALLURION TECHNOLOGIES INC (ALUR) is 2.84% of its float. Check the ownership tab for more information on the ALUR short interest.
ChartMill assigns a technical rating of 4 / 10 to ALUR. When comparing the yearly performance of all stocks, ALUR is a bad performer in the overall market: 95.49% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to ALUR. ALUR has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months ALUR reported a non-GAAP Earnings per Share(EPS) of -9.46.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -80.87% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 82% to ALUR. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of -174.54% and a revenue growth -10.39% for ALUR